Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Encompass Health Corporation

Investors looking for undervalued stocks in the current volatile market may want to pay close attention to Wall Street’s latest picks. These stocks...

3 “Strong Buy” Value Stocks with Over 30% Upside, According to Analysts – 12/9/2025

In a report released today, Matthew Taylor from Jefferies maintained a Buy rating on GE Healthcare Technologies Inc, with a price target of $95.00....

Jefferies Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)

In a report released today, Matt Miksic from Barclays maintained a Hold rating on GE Healthcare Technologies Inc, with a price target of $86.00. Mi...

Barclays Reaffirms Their Hold Rating on GE Healthcare Technologies Inc (GEHC)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PTC Therapeutics (PTCT – Research Report), ALX Onc...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: PTC Therapeutics (PTCT), ALX Oncology Holdings (ALXO) and Encompass Health (EHC)

An update from Encompass Health ( ($EHC) ) is now available. Encompass Health has announced that it does not provide guidance on a GAAP basis for c...

Encompass Health Updates 2025 Financial Guidance Approach

Jefferies Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Barclays analyst Matt Miksic maintained a Hold rating on GE Healthcare Technologies Inc today and set a price target of $86.00. According to TipRan...

Barclays Sticks to Their Hold Rating for GE Healthcare Technologies Inc (GEHC)

In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on GE Healthcare Technologies Inc, with a price target of $91.0...

Piper Sandler Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)

23andMe Holding ( ($MEHCQ) ) has provided an update. On March 23, 2025, Chrome Holding Co., formerly known as 23andMe Holding Co., along with its s...

Market Cap	$11.26B	P/E Ratio	20.06
52W High	$127.99	52W Low	$87.85
Div Yield	76.0%	Payout Ratio	59.7%
EPS Growth 3Y	-33.9%	52W Position	46.0%
Overall Score	62	Value Score	85
Quality Score	60	Technical Score	41

EPS Current Est	$5.3	EPS Next Est	$5.8
EPS Growth Est	+9.4%	DPS Growth 3Y	-17.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	EHC	$106.33	-0.07%	486.20K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	EHC	$106.33	-0.1%	486.20K
3
4
5
6

EHC

EHC

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Encompass Health Corporation Data in Excel

Get Encompass Health Corporation Data in Excel